NervGen: Data For Spinal Cord Injury Treatment Candidate Likely For Mid-2025
NervGen's groundbreaking NVG-291 treatment for spinal cord injury is currently in trials with FDA Fast Track Designation.
rheumatologyadvisor3d
Vertebral Fractures Linked to Progressive Spinal Degeneration in Longitudinal Study
Patients with vertebral fractures, particularly severe fractures, may face greater risks for worsening spinal degeneration.
MassDevice6d
Onward wins FDA nod for non-invasive spinal cord stim
Onward Medical announced today that it received FDA de novo clearance for its ARC-EX spinal cord stimulation (SCS) system.
Onward wins FDA approval for ARC-EX system in spinal cord injury patients
Shares in the company were up 7% at market open following the first approval for a non-invasive spinal cord stimulator for ...